1620 Investment Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$27.7K	Sell	503 -925	-65%	-$50.8K	0.02%	366
2025 Q1	$101K	Sell	1,428 -6	-0.4%	-$424	0.08%	213
2024 Q4	$94.3K	Buy	1,434 +86	+6%	+$5.65K	0.07%	228
2024 Q3	$94.8K	Buy	1,348 +25	+2%	+$1.76K	0.07%	238
2024 Q2	$109K	Buy	+1,323	New	+$109K	0.08%	206